Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $6.3 million.

  • Jaguar Health's Cash from Financing Activities rose 7730.88% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year decrease of 5362.7%. This contributed to the annual value of $31.2 million for FY2024, which is 883.81% down from last year.
  • Jaguar Health's Cash from Financing Activities amounted to $6.3 million in Q3 2025, which was up 7730.88% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Cash from Financing Activities ranged from a high of $30.9 million in Q1 2021 and a low of $373000.0 during Q3 2021
  • Moreover, its 5-year median value for Cash from Financing Activities was $5.0 million (2025), whereas its average is $7.7 million.
  • As far as peak fluctuations go, Jaguar Health's Cash from Financing Activities skyrocketed by 262037.53% in 2022, and later crashed by 8611.41% in 2023.
  • Over the past 5 years, Jaguar Health's Cash from Financing Activities (Quarter) stood at $3.1 million in 2021, then crashed by 47.52% to $1.6 million in 2022, then skyrocketed by 550.18% to $10.6 million in 2023, then plummeted by 73.43% to $2.8 million in 2024, then skyrocketed by 121.17% to $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q3 2025, $2.7 million for Q2 2025, and $5.0 million during Q1 2025.